Receptors, Interleukin-10
"Receptors, Interleukin-10" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Cell surface receptors for INTERLEUKIN-10. They exist as a tetramer of two alpha chains (INTERLEUKIN-10 RECEPTOR ALPHA CHAIN) and two beta chains (INTERLEUKIN-10 RECEPTOR, BETA CHAIN). Signaling from interleukin-10 receptors occurs through their interaction with JANUS KINASES.
MeSH Number(s)
D12.776.543.750.705.852.420.550
Concept/Terms
Receptors, Interleukin-10- Receptors, Interleukin-10
- Receptors, Interleukin 10
- Interleukin-10 Receptor
- Interleukin 10 Receptor
- Receptor, Interleukin-10
- Receptor, Interleukin 10
- Receptors, IL-10
- IL-10 Receptors
- Receptors, IL 10
- IL-10 Receptor
- IL 10 Receptor
- Receptor, IL-10
- Interleukin-10 Receptors
- Interleukin 10 Receptors
Below are MeSH descriptors whose meaning is more general than "Receptors, Interleukin-10".
Below are MeSH descriptors whose meaning is more specific than "Receptors, Interleukin-10".
This graph shows the total number of publications written about "Receptors, Interleukin-10" by people in Harvard Catalyst Profiles by year, and whether "Receptors, Interleukin-10" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1997 | 0 | 1 | 1 |
1999 | 0 | 1 | 1 |
2008 | 0 | 2 | 2 |
2009 | 0 | 1 | 1 |
2011 | 0 | 2 | 2 |
2014 | 2 | 0 | 2 |
2016 | 1 | 4 | 5 |
2017 | 3 | 1 | 4 |
2018 | 1 | 1 | 2 |
2020 | 1 | 1 | 2 |
2022 | 0 | 2 | 2 |
2023 | 0 | 1 | 1 |
Below are the most recent publications written about "Receptors, Interleukin-10" by people in Profiles.
-
The IL-10 receptor inhibits cell extrinsic signals necessary for STAT1-dependent macrophage accumulation during colitis. Mucosal Immunol. 2023 06; 16(3):233-249.
-
Pathogenic Interleukin-10 Receptor Alpha Variants in Humans - Balancing Natural Selection and Clinical Implications. J Clin Immunol. 2023 02; 43(2):495-511.
-
Facile discovery of surrogate cytokine agonists. Cell. 2022 04 14; 185(8):1414-1430.e19.
-
Interleukin-10 receptor signaling promotes the maintenance of a PD-1int TCF-1+ CD8+ T cell population that sustains anti-tumor immunity. Immunity. 2021 12 14; 54(12):2825-2841.e10.
-
Clinical and Mutation Description of the First Iranian Cohort of Infantile Inflammatory Bowel Disease: The Iranian Primary Immunodeficiency Registry (IPIDR). Immunol Invest. 2021 May; 50(4):445-459.
-
Alterations in T and B Cell Receptor Repertoires Patterns in Patients With IL10 Signaling Defects and History of Infantile-Onset IBD. Front Immunol. 2020; 11:109.
-
Lambda interferons come to light: dual function cytokines mediating antiviral immunity and damage control. Curr Opin Immunol. 2019 02; 56:67-75.
-
The Treatment of Inflammatory Bowel Disease in Patients with Selected Primary Immunodeficiencies. J Clin Immunol. 2018 07; 38(5):579-588.
-
Type I interferon signaling restrains IL-10R+ colonic macrophages and dendritic cells and leads to more severe Salmonella colitis. PLoS One. 2017; 12(11):e0188600.
-
Enhanced TH17 Responses in Patients with IL10 Receptor Deficiency and Infantile-onset IBD. Inflamm Bowel Dis. 2017 11; 23(11):1950-1961.